Delivery Order V797D50358-36C24719F0080
Award Date 10/19/18
Potential Completion Date 11/14/18
Potential Value $35K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
King of Prussia, PA 19406, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- Veterans Integrated Service Network 8 issued a $183,902.60 delivery order to CSL Behring L.L.C. on July 29, 2026, for 3,000 units per vial of HAEGARDA (C1 inhibitor injection solution) under the Pharmaceuticals and Drugs GSA Schedule (FSS-61-IB). The order is issued under GSA's multiple-award Federal Supply Schedule for pharmaceuticals and drugs, with a parent ceiling of $201.48 million valid through September 29, 2026. Place of performance is King of Prussia, Pennsylvania, where CSL Behring...
- This $415,866.00 firm fixed price purchase order was awarded by the Department of Veterans Affairs (VA) Veterans Health Administration to CSL Behring L.L.C., a global biotherapeutics company, to provide the Hereditary Angioedema treatment HAEGARDA. The contract has a completion date of September 30, 2018 and has no set-aside designation. CSL Behring supplies specialty pharmaceuticals to federal agencies including the VA under a Pharmaceuticals and Drugs Federal Supply Schedule contract managed...
- The Department of Veterans Affairs Veterans Health Administration (VA VHA) awarded a firm fixed price delivery order under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) to CSL Behring L.L.C., a global biotherapeutics company, for the supply of HAEGARDA, a treatment for Hereditary Angioedema. The $159,520.06 order was placed by VA's Veterans Integrated Service Network 22 with a completion date of November 25, 2019. CSL Behring, the prime contractor, has provided specialty...
- CSL Behring L.L.C. was awarded a $35,182.72 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9. This firm fixed price order is for 3,000 units of HAEGARDA injection to be delivered to a location in King of Prussia, Pennsylvania by January 28, 2022. The FSS contract functions as a large purchasing vehicle managed by the General Services...
- CSL Behring L.L.C. was awarded a $52,774.08 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 19. The delivery order is for 24 vials of HAEGARDA, a pharmaceutical product, with 3000 units per vial. The contract has a firm fixed price and period of performance through September 26, 2022. No set-aside designation was used for this award issued under the...
- This is a delivery order awarded by the Veterans Integrated Service Network 8 (VISN 8), a division of the U.S. Department of Veterans Affairs (VA), to CSL Behring L.L.C. for the supply of 72 units of the pharmaceutical product HAEGARDA (a C1 inhibitor for hereditary angioedema). The contract has a firm fixed price of $87,207.54 and an ultimate completion date of April 28, 2021. This delivery order was placed against CSL Behring's primary Federal Supply Schedule contract for Pharmaceuticals and...
- This federal contract award was issued by the Department of Veterans Affairs (VA) Veterans Health Administration's Veterans Integrated Service Network 7 to the prime contractor CSL Behring L.L.C., doing business as CSL Behring LLC. The contract is a Delivery Order against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration, with a firm fixed price of $103,831.50 and no set-aside designation. The award is for the supply of HAEGARDA...
- The Department of Veterans Affairs (VA) Veterans Health Administration awarded a firm fixed price delivery order to CSL Behring L.L.C., a global biotherapeutics company, to provide the specialty pharmaceutical HAEGARDA. This $125,412.60 contract was not set aside and was issued against CSL Behring's existing Pharmaceuticals and Drugs Federal Supply Schedule contract with the VA and General Services Administration (GSA). The delivery was designated for the VA Greater Los Angeles Healthcare...
- This federal contract award to CSL Behring L.L.C., doing business as CSL Behring LLC, is for the delivery of HAEGARDA medication to the Department of Veterans Affairs (VA) Veterans Health Administration (VHA) Veterans Integrated Service Network 7. The $104,510.10 firm fixed price delivery order was issued against CSL Behring's Pharmaceuticals and Drugs Federal Supply Schedule contract with the General Services Administration (GSA). The contract has no set-aside designation. CSL Behring, a global...
- CSL Behring L.L.C. was awarded a $193,504.96 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB) by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 22. The firm fixed price order is for the emergency delivery of Haegarda vaccines to the place of performance in King of Prussia, Pennsylvania, with completion required by September 30, 2022. No set-aside designation was applied to this award made under the...